Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modeling pharmacokinetic data using heavy-tailed multivariate distributions.

J K Lindsey1, B Jones

  • 1Department of Medical Statistics, De Montfort University, Leicester, United Kingdom.

Journal of Biopharmaceutical Statistics
|August 26, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of an antiperspirant with emollients on foot-sweat accumulation and blister formation while walking in the heat.

Journal of the American Academy of Dermatology·1995
Same author

The achievement of isoeffective bronchial mucosal dose during endobronchial brachytherapy.

International journal of radiation oncology, biology, physics·1995
Same author

Entry of microbes into the host: using M cells to break the mucosal barrier.

Current opinion in immunology·1995
Same author

Derivation of the optimum dose per fraction from the linear quadratic model.

The British journal of radiology·1995
Same author

On the nature of the mutation in the nude rat.

Trends in genetics : TIG·1995
Same author

Radiotherapy and chemotherapy for inoperable non-small cell lung cancer.

Postgraduate medical journal·1995
Same journal

Correction.

Journal of biopharmaceutical statistics·2026
Same journal

Leveraging external controls in clinical trials: estimands, estimation, assumptions.

Journal of biopharmaceutical statistics·2026
Same journal

Special issue of nonclinical statistics in regulatory applications guest editors' notes.

Journal of biopharmaceutical statistics·2026
Same journal

Comparison of flexible parametric modeling and nonparametric methods to estimate restricted mean survival time: A simulation study.

Journal of biopharmaceutical statistics·2026
Same journal

Simulated treatment comparisons with jackknife pseudo values for estimating population-adjusted marginal treatment effects.

Journal of biopharmaceutical statistics·2026
Same journal

Sample sizes for randomized controlled trials utilizing Bayesian response adaptive randomization for continuous outcomes.

Journal of biopharmaceutical statistics·2026
See all related articles

This study introduces advanced statistical models for analyzing drug pharmacokinetic data, improving accuracy in modeling complex dependencies and handling extreme values in clinical trials.

Area of Science:

  • Pharmacometrics
  • Biostatistics
  • Clinical Pharmacology

Background:

  • Pharmacokinetic (PK) studies, crucial for drug development (Phases I and II), often use crossover trials with longitudinal data.
  • Analyzing PK data involves complex dependencies within and between trial periods, typically modeled using multivariate normal distributions.
  • Existing methods struggle with the heavy tails and serial dependencies inherent in PK data.

Purpose of the Study:

  • To develop and apply novel statistical models for PK data analysis.
  • To better handle complex dependencies, including subject and period effects, and time-varying variances.
  • To incorporate heavy-tailed distributions and advanced serial dependence structures for improved modeling.

Main Methods:

  • Introduction of multivariate power exponential and Student t distributions to accommodate heavy tails.

Related Experiment Videos

  • Modeling serial dependence using an integrated Ornstein-Uhlenbeck (IOU) process, outperforming conventional CAR(1) models.
  • Application of these enhanced models to a Phase I clinical trial dataset for flosequinan and its metabolite.

    • Main Results:

    • The proposed models effectively handle complex dependencies in longitudinal PK data.
    • Heavy-tailed distributions proved essential for managing extreme observations common in PK studies.
    • The IOU process demonstrated superior fit for serial dependence compared to standard autoregressive models.

    Conclusions:

    • Advanced statistical modeling using heavy-tailed distributions and IOU processes offers a more robust approach to PK data analysis.
    • These methods enhance the accuracy of pharmacokinetic modeling in clinical trials.
    • The findings have implications for better understanding drug and metabolite behavior in vivo.